Journal of General Virology, Vol 79, 2191-2201, Copyright © 1998 by Society for General Microbiology

ARTICLES

Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses

MR Klein, SH van der Burg, E Hovenkamp, AM Holwerda, JW Drijfhout, CJ Melief and F Miedema
Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, and University of Amsterdam.

HLA-B57 has been shown to be strongly associated with slow disease progression in human immunodeficiency virus type 1 (HIV-1)-infected patients from the Amsterdam Cohort. Since HIV-1-specific CTL can control and eliminate virus-infected cells, we sought to characterize the dominant HLA-B57-restricted CTL responses at the epitope level. It was found that HLA-B57-restricted CTL responses were targeted at multiple proteins of HIV-1, with CTL specific for Gag and RT being the most pronounced. Gag-specific CTL recognized peptides ISPRTLNAW (aa 147- 155) and STLQEQIGW (aa 241-249), which had previously been reported as HLA-B57-restricted. The RT-specific CTL response in one long-term survivor studied in great detail persisted for > 10 years and was dominated by HLA-B57-restricted CTL that recognized the newly defined epitope IVLPEKDSW (RT(LAI), aa 244-252). This epitope could be recognized in the context of both HLA-B*5701 and HLA-B*5801. Interestingly, three epitope variants of IVLPEKDSW were observed, which coincided with the strongest detectable CTL response to RT. One variant (T2E7) was not recognized by IVLPEKDSW-specific CTL despite the fact that this variant bound to HLA-B*5701 with a similar affinity as the index peptide. Finally, only viruses which contained the epitope index sequence were obtained suggesting efficient virus control by CTL. In conclusion, we report the characterization of dominant HIV-1 Gag- and RT-derived, HLA-B57-restricted CTL epitopes which are associated with longer time to AIDS. Further characterization of CTL responses restricted by HLA-B57 and other protective HLA alleles may contribute to the development of effective AIDS vaccines.

This article has been cited by other articles:

				M. Daucher, D. A. Price, J. M. Brenchley, L. Lamoreaux, J. A. Metcalf, C. Rehm, E. Nies-Kraske, E. Urban, C. Yoder, D. Rock, et al. Virological Outcome after Structured Interruption of Antiretroviral Therapy for Human Immunodeficiency Virus Infection Is Associated with the Functional Profile of Virus-Specific CD8+ T Cells J. Virol., April 15, 2008; 82(8): 4102 - 4114. [Abstract] [Full Text] [PDF]

				M. Navis, I. Schellens, D. van Baarle, J. Borghans, P. van Swieten, F. Miedema, N. Kootstra, and H. Schuitemaker Viral Replication Capacity as a Correlate of HLA B57/B5801-Associated Nonprogressive HIV-1 Infection J. Immunol., September 1, 2007; 179(5): 3133 - 3143. [Abstract] [Full Text] [PDF]

				K. L. Schaubert, D. A. Price, N. Frahm, J. Li, H. L. Ng, A. Joseph, E. Paul, B. Majumder, V. Ayyavoo, E. Gostick, et al. Availability of a Diversely Avid CD8+ T Cell Repertoire Specific for the Subdominant HLA-A2-Restricted HIV-1 Gag p2419-27 Epitope J. Immunol., June 15, 2007; 178(12): 7756 - 7766. [Abstract] [Full Text] [PDF]

				G. B. E. Stewart-Jones, G. Gillespie, I. M. Overton, R. Kaul, P. Roche, A. J. McMichael, S. Rowland-Jones, and E. Y. Jones Structures of Three HIV-1 HLA-B*5703-Peptide Complexes and Identification of Related HLAs Potentially Associated with Long-Term Nonprogression J. Immunol., August 15, 2005; 175(4): 2459 - 2468. [Abstract] [Full Text] [PDF]

				R. Chakraborty, A.-S. Morel, J. K. Sutton, V. Appay, R. M. Ripley, T. Dong, T. Rostron, S. Ogola, T. Palakudy, R. Musoke, et al. Correlates of Delayed Disease Progression in HIV-1-Infected Kenyan Children J. Immunol., June 15, 2005; 174(12): 8191 - 8199. [Abstract] [Full Text] [PDF]

				A. Leslie, D. Kavanagh, I. Honeyborne, K. Pfafferott, C. Edwards, T. Pillay, L. Hilton, C. Thobakgale, D. Ramduth, R. Draenert, et al. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA J. Exp. Med., March 21, 2005; 201(6): 891 - 902. [Abstract] [Full Text] [PDF]

				J. T. Loffredo, J. Sidney, C. Wojewoda, E. Dodds, M. R. Reynolds, G. Napoe, B. R. Mothe, D. H. O'Connor, N. A. Wilson, D. I. Watkins, et al. Identification of Seventeen New Simian Immunodeficiency Virus-Derived CD8+ T Cell Epitopes Restricted by the High Frequency Molecule, Mamu-A*02, and Potential Escape from CTL Recognition J. Immunol., October 15, 2004; 173(8): 5064 - 5076. [Abstract] [Full Text] [PDF]

				A. M. Martin, D. Nolan, S. Gaudieri, C. A. Almeida, R. Nolan, I. James, F. Carvalho, E. Phillips, F. T. Christiansen, A. W. Purcell, et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant PNAS, March 23, 2004; 101(12): 4180 - 4185. [Abstract] [Full Text] [PDF]

				D. H. O'Connor, B. R. Mothe, J. T. Weinfurter, S. Fuenger, W. M. Rehrauer, P. Jing, R. R. Rudersdorf, M. E. Liebl, K. Krebs, J. Vasquez, et al. Major Histocompatibility Complex Class I Alleles Associated with Slow Simian Immunodeficiency Virus Disease Progression Bind Epitopes Recognized by Dominant Acute-Phase Cytotoxic-T-Lymphocyte Responses J. Virol., August 15, 2003; 77(16): 9029 - 9040. [Abstract] [Full Text] [PDF]

				F. Buseyne and Y. Riviere The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes Int. Immunol., July 1, 2001; 13(7): 941 - 950. [Abstract] [Full Text] [PDF]

				D. van Baarle, E. Hovenkamp, M. F. C. Callan, K. C. Wolthers, S. Kostense, L. C. Tan, H. G. M. Niesters, A. D. M. E. Osterhaus, A. J. McMichael, M. H. J. van Oers, et al. Dysfunctional Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma Blood, July 1, 2001; 98(1): 146 - 155. [Abstract] [Full Text] [PDF]

				C. M. Hogan and S. M. Hammer Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics Ann Intern Med, May 15, 2001; 134(10): 978 - 996. [Abstract] [Full Text] [PDF]

				P. J. R. Goulder, Y. Tang, S. I. Pelton, and B. D. Walker HLA-B57-Restricted Cytotoxic T-Lymphocyte Activity in a Single Infected Subject toward Two Optimal Epitopes, One of Which Is Entirely Contained within the Other J. Virol., June 1, 2000; 74(11): 5291 - 5299. [Abstract] [Full Text]

				R. Kaul, F. A. Plummer, J. Kimani, T. Dong, P. Kiama, T. Rostron, E. Njagi, K. S. MacDonald, J. J. Bwayo, A. J. McMichael, et al. HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi J. Immunol., February 1, 2000; 164(3): 1602 - 1611. [Abstract] [Full Text] [PDF]

				H. Hendel, S. Caillat-Zucman, H. Lebuanec, M. Carrington, S. O'Brien, J.-M. Andrieu, F. Schachter, D. Zagury, J. Rappaport, C. Winkler, et al. New Class I and II HLA Alleles Strongly Associated with Opposite Patterns of Progression to AIDS J. Immunol., June 1, 1999; 162(11): 6942 - 6946. [Abstract] [Full Text] [PDF]